Latest / The Holistic Fertility Show / Can NAC help you have a baby even with endometriosis?
Transcript
- 0:00SPEAKER_00: Imagine being told that um a simple widely available over-the-counter supplement.
- 0:05SPEAKER_01: Something you might pick up for like$15 at the pharmacy.
- 0:08SPEAKER_00: Right, exactly.
- 0:09SPEAKER_00: Imagine that this supplement not only shrank endometriosis cysts in a recent clinical trial, but actually resulted in a 75% pregnancy rate for the women trying to conceive.
- 0:20SPEAKER_01: Aaron Powell It is a wild statistic.
- 0:24SPEAKER_01: It really is.
- 0:25SPEAKER_00: Today we are looking at a 2023 study on N-acetylcysteine or uh NAC that basically has the whole women's health space buzzing.
- 0:35SPEAKER_01: Oh, absolutely.
- 0:36SPEAKER_01: It's everywhere right now.
- 0:37SPEAKER_00: Aaron Powell But we have to ask, you know, is this a genuine biochemical breakthrough for what is honestly a notoriously stubborn condition, or is it just like a masterclass in why medical science desperately needs control groups?
- 0:52SPEAKER_01: Yeah, that is the big question.
- 0:54SPEAKER_00: Welcome to your custom tailored deep dive.
- 0:57SPEAKER_00: We are taking you straight into the messy, murky, and just incredibly fascinating world of chronic disease management.
- 1:03SPEAKER_01: Aaron Powell Because it's a study that perfectly captures this um this tension between the very real, very desperate hope of patients and the rigid demands of the scientific method.
- 1:13SPEAKER_00: Aaron Powell Which can feel so cold sometimes.
- 1:15SPEAKER_01: It can.
- 1:16SPEAKER_01: But I mean, endometriosis affects roughly one in ten women of reproductive age, right?
- 1:22SPEAKER_00: And the current standard of care which is usually what, a carousel of hormonal suppression.
- 1:27SPEAKER_01: Yeah.
- 1:27SPEAKER_01: Hormones or repeated surgeries.
- 1:29SPEAKER_01: It leaves this massive gap.
- 1:31SPEAKER_01: So breaking down how this specific, you know, amino acid derivative interacts with the body's inflammatory pathways, it's going to give you a highly grounded perspective on where the research is actually heading.
- 1:42SPEAKER_00: Okay.
- 1:43SPEAKER_00: Let's unpack this.
- 1:44SPEAKER_01: Okay.
- 1:44SPEAKER_00: Because whether you are, you know, navigating this diagnosis yourself or maybe prepping for a meeting on reproductive endocrinology, or honestly, if you are just insanely curious about cellular biology, this study is a wild ride.
- 1:58SPEAKER_01: Aaron Powell It really is.
- 1:59SPEAKER_01: There is so much to dig into.
- 2:01SPEAKER_00: But uh before we look at the results from those 120 women in the trial, I think we need to set the biochemical stage a bit.
- 2:07SPEAKER_01: Aaron Powell Right.
- 2:08SPEAKER_01: Get the basics down.
- 2:09SPEAKER_00: Aaron Powell Yeah.
- 2:09SPEAKER_00: Because we hear the term knack thrown around a lot, like in longevity circles and biohacking forums.
- 2:16SPEAKER_00: But what is it actually doing inside the human body?
- 2:18SPEAKER_00: Specifically in the context of a hyperinflammatory condition like endometriosis.
- 2:23SPEAKER_01: Aaron Powell So to really understand knack, you have to understand the body's master antioxidant.
- 2:28SPEAKER_00: Okay.
- 2:29SPEAKER_01: Glutathion.
- 2:30SPEAKER_00: Oh, right.
- 2:30SPEAKER_00: I've definitely seen that on vitamin bottles.
- 2:32SPEAKER_00: Trevor Burrus, Jr.
- 2:32SPEAKER_01: Yeah, it's popular.
- 2:34SPEAKER_01: Your body naturally produces glutathione to basically protect your cells from oxidative stress.
- 2:39SPEAKER_00: Right.
- 2:40SPEAKER_01: Now, oxidative stress occurs when there is an imbalance.
- 2:44SPEAKER_01: An imbalance between free radicals, which are those are the bad guys, right?
- 2:48SPEAKER_01: Well, they're just unstable molecules produced during normal cellular metabolism.
- 2:52SPEAKER_01: But you have an imbalance between those and the antioxidants available to neutralize them.
- 2:57SPEAKER_00: Okay, so they need to cancel each other out.
- 2:59SPEAKER_01: Exactly.
- 3:00SPEAKER_01: In a healthy system, it is a beautifully balanced equation.
- 3:04SPEAKER_01: But in a condition like endometriosis, the system is just chronically overwhelmed.
- 3:09SPEAKER_00: Aaron Powell The free radicals are winning.
- 3:11SPEAKER_01: Yeah.
- 3:12SPEAKER_01: The free radicals run rampant and they cause cellular damage, which drives this relentless inflammatory response.
- 3:19SPEAKER_00: Aaron Powell Let me um let me try a different way to visualize this for you guys listening.
- 3:23SPEAKER_00: If oxidative stress is like, say, rust slowly forming on the undercarriage of a car.
- 3:28SPEAKER_01: Okay, I like that.
- 3:29SPEAKER_00: Right.
- 3:29SPEAKER_00: Then glutathione is basically acting like the protective anti-rust coating for the cells.
- 3:34SPEAKER_01: Aaron Powell What's fascinating here is how perfectly that analogy captures the specific pathology we're dealing with.
- 3:40SPEAKER_00: Aaron Powell Really?
- 3:41SPEAKER_00: How so?
- 3:42SPEAKER_01: Aaron Ross Powell Because when endometrial-like tissue implants outside the uterus, it triggers an immune response.
- 3:47SPEAKER_01: Right.
- 3:48SPEAKER_01: Your body senses tissue where it absolutely shouldn't be.
- 3:51SPEAKER_00: It's like what is this doing here?
- 3:52SPEAKER_01: Aaron Ross Powell Exactly.
- 3:53SPEAKER_01: So it sends in macrophages to clean it up.
- 3:56SPEAKER_01: But in endometriosis, those macrophages often become dysfunctional.
- 4:00SPEAKER_00: They don't do their job.
- 4:01SPEAKER_01: Right.
- 4:01SPEAKER_01: Instead of clearing the tissue, they just secrete these inflammatory cytokines, which generate even more of that cellular rust.
- 4:09SPEAKER_00: Oh wow.
- 4:09SPEAKER_01: Yeah.
- 4:10SPEAKER_01: More reactive oxygen species or ROS.
- 4:13SPEAKER_01: And this massive oxidative stress actually promotes the adhesion and growth of those lesions.
- 4:18SPEAKER_01: It's this vicious self-perpetuating cycle.
- 4:21SPEAKER_00: Aaron Ross Powell So the car is just getting rustier and rustier and the body can't keep up with the anti-rust coating?
- 4:27SPEAKER_01: Precisely.
- 4:28SPEAKER_01: So NAC isn't swooping in to fight the rust directly.
- 4:31SPEAKER_01: It's what we call a rate limiting precursor.
- 4:34SPEAKER_00: Aaron Ross Powell Meaning it provides the raw materials?
- 4:36SPEAKER_01: Yes.
- 4:37SPEAKER_01: It supplies the specific amino acid, cysteine, that your cells desperately need to synthesize more of their own glutathione.
- 4:45SPEAKER_01: It gives the body the tools to spray down that anti-rust coating itself.
- 4:48SPEAKER_00: Okay, which makes the design of this 2023 study so intriguing.
- 4:53SPEAKER_00: We have this clear picture of the cellular battlefield now.
- 4:56SPEAKER_00: We know we are trying to arm the body with more cysteine.
- 4:59SPEAKER_00: Right.
- 4:59SPEAKER_00: But the researchers didn't just, you know, hand a bottle of pills to the 120 women and say, like, take one a day and call me in three months.
- 5:06SPEAKER_01: No, not at all.
- 5:08SPEAKER_00: The dosing protocol was highly specific and frankly a little weird.
- 5:12SPEAKER_01: Aaron Ross Powell It was rigorously structured.
- 5:14SPEAKER_01: So very intentional.
- 5:16SPEAKER_00: So they gave them 600 milligrams of NAC.
- 5:19SPEAKER_01: Taken three times a day.
- 5:20SPEAKER_00: Morning, afternoon, and evening.
- 5:22SPEAKER_00: Which I mean that part tracks, right?
- 5:23SPEAKER_00: Given the relatively short half-life of the compound, you'd want to keep the blood level steady all day.
- 5:28SPEAKER_01: Yeah, that's standard pharmacokinetics.
- 5:31SPEAKER_01: But the critical detail, the part that's really unique, is that they only took that dose on three consecutive days each week.
- 5:38SPEAKER_00: Okay, so like taking the NAC on Monday, Tuesday, and Wednesday?
- 5:42SPEAKER_01: Exactly.
- 5:43SPEAKER_01: And then for Thursday, Friday, Saturday, and Sunday, they took absolutely nothing.
- 5:46SPEAKER_00: Nothing at all.
- 5:47SPEAKER_01: Zero.
- 5:48SPEAKER_01: And they repeated this highly specific on and off cycle for exactly three months.
- 5:52SPEAKER_00: Okay, why just three days on and four days off?
- 5:55SPEAKER_00: If we are trying to, you know, clear away that cellular rust, why are we stopping the treatment for four days a week?
- 6:01SPEAKER_00: Is this to pulse the antioxidant effect so the body doesn't get used to it?
- 6:06SPEAKER_01: You hit the nail on the head.
- 6:07SPEAKER_01: That's exactly it.
- 6:09SPEAKER_01: It is entirely about cellular pulsing and maintaining homeostasis.
- 6:13SPEAKER_00: Okay.
- 6:14SPEAKER_01: See, if you flood the human body with exogenous precursors constantly, biological systems are incredibly efficient at adapting.
- 6:22SPEAKER_00: They get lazy.
- 6:23SPEAKER_01: Basically, yeah.
- 6:24SPEAKER_01: They rely on negative feedback loops.
- 6:26SPEAKER_01: If your cells sense this constant, artificially high supply of glutathione being generated, the body can actually downregulate its own natural production pathways.
- 6:36SPEAKER_00: Oh, so it creates a dependency.
- 6:37SPEAKER_01: Aaron Powell Exactly.
- 6:38SPEAKER_01: You could essentially blunt the body's innate enzymatic activity.
- 6:42SPEAKER_00: Aaron Powell So the four days offer like a washout period.
- 6:45SPEAKER_01: Precisely.
- 6:46SPEAKER_01: The four-day break allows the whole cellular environment to reset.
- 6:50SPEAKER_01: It prevents that downregulation we just talked about, and it maintains the body's sensitivity to the precursor.
- 6:55SPEAKER_00: Aaron Powell That is so clever.
- 6:56SPEAKER_01: Right.
- 6:57SPEAKER_01: In pharmacological terms, we are trying to nudge the system into a therapeutic state without triggering its defensive adaptations.
- 7:03SPEAKER_00: Aaron Powell Which brings us to the findings.
- 7:05SPEAKER_00: Because, man, we have 120 women dealing with this chronic, often totally debilitating condition, and they follow this strict pulsing regimen for three months.
- 7:15SPEAKER_00: And the researchers reported improvements across three major fronts.
- 7:19SPEAKER_00: First, they noted significant reductions in pelvic pain.
- 7:22SPEAKER_01: Aaron Powell Now pain reduction in endomesiosis is paramount, obviously.
- 7:26SPEAKER_01: But as a clinical metric, it is inherently complex to measure.
- 7:29SPEAKER_00: Aaron Powell Because it's subjective, right?
- 7:31SPEAKER_01: Chronic pain alters central nervous system processing.
- 7:34SPEAKER_01: But these participants reported notable decreases in dysmenorrhea, painful periods, and chronic pelvic pain, which, as you can imagine, dramatically alters daily quality of life.
- 7:44SPEAKER_00: Aaron Powell Yeah.
- 7:45SPEAKER_00: I mean, getting your life back from chronic pain is huge, but subjective pain scales are just one piece of the puzzle.
- 7:52SPEAKER_00: I can tell a researcher, you know, my pain dropped from an eight to a four, but you can't quantify that in a petri dish.
- 7:57SPEAKER_01: Right.
- 7:57SPEAKER_00: But here's where it gets really interesting.
- 7:59SPEAKER_00: The study didn't just rely on subjective questionnaires.
- 8:02SPEAKER_01: No, they didn't.
- 8:03SPEAKER_00: The second major finding was physical reductions in the size of ovarian endometriomas.
- 8:08SPEAKER_00: Like they actually tracked the cysts shrinking on ultrasounds.
- 8:12SPEAKER_00: It's remarkable.
- 8:12SPEAKER_00: And the third finding was a drop in CA125 levels in the blood.
- 8:17SPEAKER_01: Right.
- 8:17SPEAKER_01: And if we connect this to the bigger picture, seeing CA125 levels plummeting alongside physical shrinkage at an ultrasound, that is a profound clinical signal.
- 8:27SPEAKER_00: Trevor Burrus Because it's objective data.
- 8:29SPEAKER_01: Exactly.
- 8:30SPEAKER_01: We aren't just relying on subjective pain skills anymore.
- 8:34SPEAKER_01: We are seeing systemic inflammatory markers retreat.
- 8:37SPEAKER_01: CA125 is a protein that is highly associated with the inflammatory burden of endometriosis.
- 8:44SPEAKER_00: So when it drops.
- 8:45SPEAKER_01: When a patient says they feel better, that is a victory.
- 8:49SPEAKER_01: But when that feeling is paired with radiological evidence of shrinking lesions and serological evidence of reduced systemic inflammation, it strongly suggests that the underlying biological environment of the disease is actually shifting.
- 9:04SPEAKER_01: We are moving from merely masking symptoms to potentially altering the disease progression itself.
- 9:10SPEAKER_00: It's like the difference between taking a painkiller so you can ignore a broken ankle versus actually putting a cast on it and watching the bone knit back together.
- 9:19SPEAKER_01: Aaron Powell That's a great way to put it.
- 9:21SPEAKER_01: We are seeing structural and biochemical changes here.
- 9:24SPEAKER_00: Aaron Powell But there is a secondary finding in the study that we have to discuss because it tackles one of the most emotionally devastating aspects of endometriosis for so many patients, and that is fertility.
- 9:34SPEAKER_01: Aaron Powell Yes.
- 9:35SPEAKER_01: The study tracked the reproductive outcomes of the participants very, very closely.
- 9:39SPEAKER_00: Aaron Ross Powell Because a lot of them wanted to have a baby, right?
- 9:42SPEAKER_01: Aaron Powell Out of the 120 women in the trial, 52 explicitly stated that their primary goal was to conceive.
- 9:50SPEAKER_00: 52 women actively trying to get pregnant while dealing with a condition that creates basically an incredibly hostile environment for fertilization and implantation.
- 9:58SPEAKER_01: Aaron Powell Right.
- 9:59SPEAKER_01: The oxidative stress makes it very difficult.
- 10:02SPEAKER_01: And of those 52 women, 39 reported achieving pregnancy within six months of beginning the trial.
- 10:09SPEAKER_00: Wait.
- 10:10SPEAKER_00: Thirty-nine out of fifty-two.
- 10:11SPEAKER_01: Yes.
- 10:12SPEAKER_00: If we look at that purely as a statistic, that is a massive batting average.
- 10:18SPEAKER_00: Like 39 out of 52 is a 75% success rate.
- 10:22SPEAKER_01: It is exceptionally high.
- 10:23SPEAKER_00: 75%.
- 10:25SPEAKER_00: For fertility outcomes.
- 10:27SPEAKER_00: In a population where spontaneous conception is notoriously heartbreakingly difficult.
- 10:33SPEAKER_01: Yes.
- 10:34SPEAKER_00: But um I have to push back here.
- 10:36SPEAKER_01: Please do.
- 10:37SPEAKER_00: Because wait, those numbers almost sound too good to be true.
- 10:40SPEAKER_00: Can we really attribute all of that just to the knack?
- 10:42SPEAKER_00: To a three-day-a-week supplement?
- 10:45SPEAKER_01: And that is the crucial, critical question to ask.
- 10:48SPEAKER_01: Now, the mechanism makes biological sense, right?
- 10:51SPEAKER_00: Because of the anti-rust coating?
- 10:53SPEAKER_01: Exactly.
- 10:54SPEAKER_01: We know that severe oxidative stress in the pelvic cavity damages oocyte quality, so egg quality, and it impairs embryo implantation.
- 11:02SPEAKER_00: Aaron Powell Okay, so the environment is just too toxic.
- 11:05SPEAKER_01: Right.
- 11:06SPEAKER_01: By reducing that ROS burden, by you know, clearing the rust, NAC theoretically creates a much more hospitable environment for a pregnancy to take hold.
- 11:15SPEAKER_00: That makes sense.
- 11:16SPEAKER_01: However, as consumers of medical research, we must view a 75% success rate through a very, very rigorous lens.
- 11:23SPEAKER_00: Aaron Powell So what does this all mean?
- 11:25SPEAKER_00: We have a biologically plausible mechanism.
- 11:28SPEAKER_00: We have women reporting less pain, ultrasounds showing smaller cysts, blood work showing less inflammation, and an astronomical pregnancy rate.
- 11:36SPEAKER_00: Right.
- 11:36SPEAKER_00: But there is a massive scientific catch hanging over all of this data, isn't there?
- 11:42SPEAKER_01: Aaron Ross Powell There is.
- 11:43SPEAKER_01: This raises an important question about study design.
- 11:46SPEAKER_01: Because this 2023 trial had a fatal methodological flaw for anyone trying to declare NAC a definitive cure.
- 11:53SPEAKER_00: Aaron Powell And what's that?
- 11:54SPEAKER_01: It had absolutely no control group.
- 11:57SPEAKER_00: Oh.
- 11:58SPEAKER_01: Meaning that there was no parallel group of women taking like a placebo pill on that exact same three days on, four days off schedule.
- 12:06SPEAKER_00: Precisely.
- 12:06SPEAKER_01: Without a control group, it is scientifically impossible to establish direct causation.
- 12:11SPEAKER_01: We cannot say definitively that NAC alone caused these symptom improvements or these pregnancies.
- 12:17SPEAKER_00: Aaron Powell Because you have nothing to compare it to.
- 12:19SPEAKER_01: Right.
- 12:19SPEAKER_01: In rigorous clinical trials, the control group is the anchor.
- 12:23SPEAKER_01: It isolates the variable you are testing.
- 12:25SPEAKER_00: Aaron Powell Because without it, the variables are practically infinite.
- 12:28SPEAKER_00: I mean, think about the Hawthorne effect, right?
- 12:30SPEAKER_01: Exactly.
- 12:31SPEAKER_01: Just the act of being observed changes things.
- 12:32SPEAKER_00: Aaron Powell Right.
- 12:33SPEAKER_00: Just being in a clinical trial changes human behavior.
- 12:35SPEAKER_00: If a woman is enrolled in a trial to improve her endometriosis, she might subconsciously start eating a more anti-inflammatory diet.
- 12:43SPEAKER_01: Aaron Powell You might cut back on alcohol.
- 12:44SPEAKER_00: Yeah.
- 12:45SPEAKER_00: Or her stress levels might drop simply because she finally feels supported by a medical team for the first time in years.
- 12:51SPEAKER_01: Aaron Powell And we know cortisol and stress profoundly impact fertility.
- 12:54SPEAKER_00: Aaron Powell Totally.
- 12:55SPEAKER_01: Furthermore, the placebo effect is remarkably powerful, particularly in pain management.
- 13:00SPEAKER_01: The belief that you are receiving a potent intervention can trigger actual physiological cascades that reduce the perception of pain.
- 13:07SPEAKER_01: Aaron Powell The brain is wild like that.
- 13:09SPEAKER_01: Aaron Powell It really is.
- 13:10SPEAKER_01: And regarding the pregnancies, we also have to account for statistical probability.
- 13:14SPEAKER_01: Over a six-month window, some percentage of women with mild to moderate endometriosis will conceive naturally, without any intervention at all.
- 13:22SPEAKER_00: Aaron Powell And without a control group to compare against.
- 13:25SPEAKER_01: Aaron Powell We don't know what the baseline pregnancy rate for this specific cohort of 52 women would have been anyway.
- 13:30SPEAKER_00: Aaron Ross Powell Wow.
- 13:31SPEAKER_00: Okay.
- 13:32SPEAKER_00: So we are really walking a tightrope here.
- 13:35SPEAKER_00: The data is incredibly exciting, and the biological pathway using glutathione to quench that oxidative stress is deeply, deeply logical.
- 13:43SPEAKER_01: Aaron Powell It's very elegant.
- 13:44SPEAKER_00: Aaron Powell But NAC is not a medically sanctioned cure.
- 13:47SPEAKER_00: It is an over-the-counter supplement.
- 13:49SPEAKER_00: And this study is honestly more of a neon sign pointing toward where funding needs to go next rather than a final destination.
- 13:56SPEAKER_01: Aaron Powell Yes.
- 13:57SPEAKER_01: It is a compelling foundation for phase three, double-blind, placebo controlled trials.
- 14:02SPEAKER_01: And it underscores a really critical point for anyone listening who is navigating this condition.
- 14:06SPEAKER_00: Yes, please.
- 14:07SPEAKER_01: The literature makes it explicitly clear that patients must consult their gynecologist or reproductive endocrinologist before adding NAC to their regimen.
- 14:15SPEAKER_00: Trevor Burrus, that's super important.
- 14:16SPEAKER_01: This is vital.
- 14:17SPEAKER_01: While it is accessible over the counter, altering your cellular antioxidant capacity can interact with other medications.
- 14:24SPEAKER_01: It has to be integrated into a comprehensive, professionally monitored care plan, especially if a patient is undergoing active fertility treatments like IVF.
- 14:33SPEAKER_00: Aaron Powell Yeah, you cannot just go rogue in the vitamin aisle and hope for the best.
- 14:37SPEAKER_01: Definitely not.
- 14:37SPEAKER_00: You need a care team that understands the interplay of all these compounds.
- 14:41SPEAKER_00: So let's take a step back and synthesize everything we've covered today for you guys.
- 14:46SPEAKER_00: We started with the allure of a magic bullet for endometriosis and quickly transitioned into the fascinating reality of cellular defense.
- 14:53SPEAKER_01: Aaron Powell Right.
- 14:54SPEAKER_01: We examined the mechanism of N-acetylcysteine, understanding its role not as a direct anti-inflammatory, but as a critical precursor.
- 15:02SPEAKER_01: Trevor Burrus, Jr.
- 15:02SPEAKER_00: The raw materials.
- 15:03SPEAKER_01: Aaron Powell Exactly.
- 15:04SPEAKER_01: It provides the cysteine necessary for the body to synthesize glutathione, effectively allowing the cells to weave their own anti-rust coating to smother the oxidative stress that drives the disease.
- 15:17SPEAKER_00: And we looked at the highly specific biologically deliberate protocol from that 2023 study.
- 15:22SPEAKER_00: 120 women taking 600 milligrams of NAC three times a day, strictly pulsed for three consecutive days a week.
- 15:29SPEAKER_01: Aaron Powell To prevent the body from downregulating its own natural production.
- 15:33SPEAKER_00: Aaron Ross Powell Exactly.
- 15:34SPEAKER_00: And we analyzed the profound observational results.
- 15:37SPEAKER_00: Significant reductions in subjective pelvic pain paired with objective, quantifiable decreases in the physical size of endometriomas on ultrasounds.
- 15:47SPEAKER_01: Plus those lowered CA125 inflammatory markers in the blood.
- 15:50SPEAKER_00: Right.
- 15:51SPEAKER_00: Not to mention the staggering statistic that 39 out of 52 women desiring pregnancy achieved it within six months.
- 15:58SPEAKER_01: But we anchored all of that hope in the rigorous reality of the scientific method.
- 16:03SPEAKER_00: Had to bring it back to Earth.
- 16:04SPEAKER_01: The lack of a placebo control group means we cannot definitively prove causation.
- 16:09SPEAKER_01: The countless uncontrolled variables, from diet changes to the placebo effect, mean NAC remains a highly promising avenue for future research and a potential adjunct therapy to discuss with a doctor.
- 16:20SPEAKER_00: Rather than a proven standalone cure.
- 16:23SPEAKER_01: Right.
- 16:24SPEAKER_01: It highlights the absolute necessity of critical thinking in modern healthcare.
- 16:28SPEAKER_01: You can and you should be optimistic about emerging biochemical pathways without abandoning the rigorous standards of evidence-based medicine.
- 16:36SPEAKER_00: Absolutely.
- 16:37SPEAKER_00: So as we wrap up this deep dive, we want to leave you with a thought that stretches beyond just this one supplement.
- 16:44SPEAKER_00: We spend so much time in reproductive health focusing on hormonal suppression, right?
- 16:48SPEAKER_01: Shutting down estrogen, stopping cycles.
- 16:51SPEAKER_00: Trying to basically starve the disease.
- 16:54SPEAKER_01: But consider the underlying mechanism we explored today.
- 16:57SPEAKER_00: Yeah.
- 16:58SPEAKER_01: If a relatively simple amino acid derivative, whose sole primary function is simply to give the body the raw materials to manage its own cellular exhaust, that oxidative stress.
- 17:09SPEAKER_00: The rest.
- 17:10SPEAKER_01: Right.
- 17:10SPEAKER_01: If that can yield such dramatic observational shifts in a condition as historically aggressive as endometriosis, how much of this complex systemic disease might ultimately be tied not just to hormones, but directly to the foundational metabolism and defense mechanisms of our very cells.
- 17:28SPEAKER_00: Oh wow.
- 17:28SPEAKER_00: It reframes the whole battle.
- 17:30SPEAKER_00: Like if we can just figure out how to give the human body exactly the right tools to clear away the rust and manage the stress, what other incredible, innate repairs is it capable of executing on its own?
- 17:41SPEAKER_01: It's an exciting frontier.
- 17:42SPEAKER_00: It is.
- 17:43SPEAKER_00: A deeply empowering thought to carry with you.
- 17:46SPEAKER_00: Thank you for joining us on this deep dive.
- 17:47SPEAKER_00: Stay curious, stay critical, and we will catch you next time.